Biologic switching between interleukin 17A antagonists secukinumab and ixekizumab: a 12-week, multicenter, retrospective study

被引:25
作者
Georgakopoulos, J. R. [1 ]
Phung, M. [2 ]
Ighani, A. [3 ]
Lam, K. [3 ]
Yeung, J. [3 ,4 ,5 ,6 ]
机构
[1] Western Univ, Schulich Sch Med & Dent, London, ON, Canada
[2] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada
[3] Univ Toronto, Fac Med, Toronto, ON, Canada
[4] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[5] Womens Coll Hosp, Toronto, ON, Canada
[6] Probity Med Res Inc, Waterloo, ON, Canada
关键词
D O I
10.1111/jdv.15100
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:E7 / E8
页数:2
相关论文
共 4 条
  • [1] Efficacy and safety of switching to ixekizumab in secukinumab nonresponders with plaque psoriasis: A multicenter retrospective study of interleukin 17A antagonist therapies
    Georgakopoulos, Jorge R.
    Phung, Michelle
    Ighani, Arvin
    Yeung, Jensen
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (01) : 155 - 157
  • [2] Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
    Gordon, K. B.
    Blauvelt, A.
    Papp, K. A.
    Langley, R. G.
    Luger, T.
    Ohtsuki, M.
    Reich, K.
    Amato, D.
    Ball, S. G.
    Braun, D. K.
    Cameron, G. S.
    Erickson, J.
    Konrad, R. J.
    Muram, T. M.
    Nickoloff, B. J.
    Osuntokun, O. O.
    Secrest, R. J.
    Zhao, F.
    Mallbris, L.
    Leonardi, C. L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (04) : 345 - 356
  • [3] Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
    Griffiths, Christopher E. M.
    Reich, Kristian
    Lebwohl, Mark
    van de Kerkhof, Peter
    Paul, Carle
    Menter, Alan
    Cameron, Gregory S.
    Erickson, Janelle
    Zhang, Lu
    Secrest, Roberta J.
    Ball, Susan
    Braun, Daniel K.
    Osuntokun, Olawale O.
    Heffernan, Michael P.
    Nickoloff, Brian J.
    Papp, Kim
    [J]. LANCET, 2015, 386 (9993) : 541 - 551
  • [4] A Review of Switching Biologic Agents in the Treatment of Moderate-to-Severe Plaque Psoriasis
    Hu, Yifan
    Chen, Zeyu
    Gong, Yu
    Shi, Yuling
    [J]. CLINICAL DRUG INVESTIGATION, 2018, 38 (03) : 191 - 199